Kyongbo Pharmaceutical Co Ltd Net Asset Quality Index
Kyongbo Pharmaceutical Co Ltd net asset quality index. Kyongbo Pharmaceutical Co Ltd (214390) has a Net Asset Quality Index of 40.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩367.57 Billion minus total liabilities of ₩220.58 Billion yields net assets of ₩146.99 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Kyongbo Pharmaceutical Co Ltd net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Kyongbo Pharmaceutical Co Ltd (2014–2025)
Net asset quality index of Kyongbo Pharmaceutical Co Ltd from 2014 to 2025. This chart shows how Kyongbo Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the index stands at 40.0%, representing net assets of ₩146.99 Billion against total assets of ₩367.57 Billion KRW. Check Kyongbo Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Kyongbo Pharmaceutical Co Ltd Net Asset Quality Index by Year (2014–2025)
Kyongbo Pharmaceutical Co Ltd net asset quality index by year from 2014 to 2025. The table below presents the year-by-year Net Asset Quality Index for Kyongbo Pharmaceutical Co Ltd from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Kyongbo Pharmaceutical Co Ltd market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 45.6% | ₩145.74 Billion | ₩319.54 Billion | ₩173.80 Billion | ▼ -5.9 pp |
| 2024 | 51.5% | ₩146.15 Billion | ₩283.89 Billion | ₩137.73 Billion | ▼ -2.7 pp |
| 2023 | 54.2% | ₩144.38 Billion | ₩266.31 Billion | ₩121.92 Billion | ▼ -5.5 pp |
| 2022 | 59.7% | ₩143.70 Billion | ₩240.54 Billion | ₩96.84 Billion | ▼ -1.7 pp |
| 2021 | 61.5% | ₩145.70 Billion | ₩236.98 Billion | ₩91.28 Billion | ▼ -0.1 pp |
| 2020 | 61.6% | ₩156.06 Billion | ₩253.24 Billion | ₩97.18 Billion | ▼ -1.1 pp |
| 2019 | 62.7% | ₩149.16 Billion | ₩237.82 Billion | ₩88.65 Billion | ▼ -4.5 pp |
| 2018 | 67.2% | ₩149.01 Billion | ₩221.62 Billion | ₩72.61 Billion | ▼ -1.8 pp |
| 2017 | 69.1% | ₩141.51 Billion | ₩204.87 Billion | ₩63.36 Billion | ▲ +5.6 pp |
| 2016 | 63.5% | ₩129.40 Billion | ₩203.74 Billion | ₩74.33 Billion | ▲ +0.7 pp |
| 2015 | 62.8% | ₩122.82 Billion | ₩195.49 Billion | ₩72.67 Billion | ▲ +22.2 pp |
| 2014 | 40.7% | ₩68.33 Billion | ₩168.03 Billion | ₩99.70 Billion | — |